New nerve block could ease pain after hip surgery, reduce opioid use

NCT ID NCT06688136

Completed Symptom relief Sponsor: Huazhong University of Science and Technology Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested a new nerve block (QLESP) against a standard local injection (PAI) for pain relief after total hip replacement. 68 adults aged 18-65 were enrolled. The goal was to see which method reduces opioid use and improves recovery. The new block aims to provide better pain control with fewer side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ropivacaine
What this could lead to: If QLESP works better, it could offer a safer, more effective way to manage pain after hip replacement, reducing the need for opioids and speeding up recovery.
What could go wrong: This is a small, completed trial with only 68 participants. The results may not apply to everyone, and the new block might not be better than the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REGIONAL ANAESTHESIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

REGIONAL ANAESTHESIA

Contacts and locations

Locations

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, 430022, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.